Authors: BALZARINI J BROUWER WG DAO DC OSIKA EM DECLERCQ E

Citation: J. Balzarini et al., IDENTIFICATION OF NOVEL THIOCARBOXANILIDE DERIVATIVES THAT SUPPRESS AVARIETY OF DRUG-RESISTANT MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS AT A POTENCY SIMILAR TO THAT FOR WILD-TYPE VIRUS, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1454-1466

Authors: BALZARINI J JONCKHEERE H HARRISON WA DAO DC ANNE J DECLERCQ E KARLSSON A

Citation: J. Balzarini et al., OXATHIIN CARBOXANILIDE DERIVATIVES - A CLASS OF NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS (NNRTIS) THAT ARE ACTIVE AGAINST MUTANT HIV-1 STRAINS RESISTANT TO OTHER NNRTIS, Antiviral chemistry & chemotherapy, 6(3), 1995, pp. 169-178

Authors: DAO DC FERGUSON G

Citation: Dc. Dao et G. Ferguson, (3AS(ASTERISK),9BS(ASTERISK))-(+ RO-2,9B-DIMETHYLTHIAZOLO[5,4-C]QUINOLIN-4(5H)-ONE/, Acta crystallographica. Section C, Crystal structure communications, 51, 1995, pp. 1823-1825

Authors: BUCKHEIT RW KINJERSKI TL FLIAKASBOLTZ V RUSSELL JD STUP TL PALLANSCH LA BROUWER WG DAO DC HARRISON WA SCHULTZ RJ BADER JP YANG SS

Citation: Rw. Buckheit et al., STRUCTURE-ACTIVITY AND CROSS-RESISTANCE EVALUATIONS OF A SERIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC COMPOUNDS RELATED TO OXATHIIN CARBOXANILIDE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2718-2727